New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareFOXO4-DRI vs BPC-157

FOXO4-DRI vs BPC-157

Side-by-side comparison of key properties, dosing, and research.

Anti-Aging & Longevity
FOXO4-DRI
Recovery & Repair
BPC-157
Summary
FOXO4-DRI is a D-retro-inverso peptide derived from the FOXO4 protein that selectively induces apoptosis in senescent cells. By disrupting the FOXO4-p53 interaction that keeps senescent cells alive, it triggers programmed cell death specifically in these aging, pro-inflammatory cells while sparing healthy tissue.
BPC-157 is a synthetic pentadecapeptide derived from a protective protein found in the stomach. It is one of the most extensively researched healing peptides, known for accelerating tissue repair, reducing inflammation, and protecting the gastrointestinal tract.
Half-Life
Estimated 2-4 hours (D-amino acid confers resistance to proteolysis)
4–6 hours
Admin Route
Subcutaneous, Intraperitoneal (research)
SubQ, IM, Oral
Research
Typical Dose
5 mg/kg in rodent studies; human equivalent approximately 0.5-1 mg/kg
200–500 mcg
Frequency
3 consecutive days per cycle
Once daily
Key Benefits
  • Selectively clears senescent cells (senolytics)
  • Reduces senescence-associated secretory phenotype (SASP) and chronic inflammation
  • Demonstrated restoration of physical fitness in aged mice
  • May improve healthspan and reduce age-related tissue dysfunction
  • Potential for treatment of age-related pathologies driven by cellular senescence
  • Does not affect healthy non-senescent cells at therapeutic doses
  • Accelerates wound healing and tissue repair
  • Reduces inflammation throughout the body
  • Protects and heals the gastrointestinal tract
  • Supports tendon and ligament healing
  • Promotes bone and joint health
  • May protect organs from toxins and injury
  • Supports gut-brain axis function
  • Counteracts NSAID-induced gut damage
Side Effects
  • Limited human data; largely preclinical evidence
  • Possible temporary inflammatory response as senescent cells are cleared (senolytic effect)
  • Weight loss observed at high doses in rodent studies
  • Unknown long-term safety profile in humans
  • Injection site discomfort
  • Nausea (rare)
  • Headache (rare)
  • Dizziness (rare)
Stacks With